top_ten

Top Ten most popular articles on Pharmafile.com this week

February 16, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alzheimer's disease, Roche, Top 10 news, Top ten news, Trump, biotech, drugs, pharma, pharmaceutical

Another week is finished and it’s been a disastrous one for research into a potential treatment for Alzheimer’s disease. Two of …

zappys_technology_solutions

Ovarian cancer risk may be inherited from the father, research indicates

February 16, 2018
Medical Communications, Research and Development Cancer, Roswell Park Comprehensive Cancer Centre, ovarian cancer

Researchers at the Roswell Park Comprehensive Cancer Centre in New York have published findings indicating that ovarian cancer risk may …

fda_building_web

FDA weighs up divisive change to Alzheimer’s drug assessment

February 16, 2018
Medical Communications Alzheimer's, FDA, biotech, drugs, pharma, pharmaceutical

Alzheimer’s disease (AD) is an area badly in need of a treatment, the problem is that this prospect seems to …

Roche boosts cancer efforts with $1.9 billion buyout of Flatiron Health

February 16, 2018
Medical Communications, Sales and Marketing Cancer, Flatiron health, Roche, acquisition, oncology, pharma

Roche has announced it is to acquire privately held healthcare and technology firm Flatiron Health for $1.9 billion to leverage …

stem-cell-163711_960_720

Silicon Valley-backed Celgene spin-off launches with $250m

February 16, 2018
Medical Communications, Sales and Marketing Celgene, Celularity, biotech, drugs, pharma, pharmaceutical

Biotechs are known for getting off the ground early with serious levels of financing, often based more on the acumen …

biogen_austria_238

Biogen shares hit by key Alzheimer’s drug concerns

February 15, 2018
Research and Development Alzheimer's, Biogen, MSD, Merck, biotech, drugs, pharma, pharmaceutical

Biogen made investors very nervous after it announced that it was choosing to add an additional 510 patients to its …

celltrion1

Celltrion’s Herceptin biosimilar seals EU approval

February 15, 2018
Sales and Marketing EU, Europe, Herceptin, Herzuma, celltrion, pharma

Herzuma, Celltrion’s biosimilar version of Roche/Genentech’s blockbuster immunotherapy Herceptin, has been awarded approval from the European Commission, the company has …

jj

J&J’s apalutamide scores snap FDA approval in castration-resistant prostate cancer subgroup

February 15, 2018
Sales and Marketing Cancer, Erleada, FDA, J&J, JJ, Johsnon & Johnson, apalutamide, pharma, prostate cancer

Johnson & Johnson has announced that its androgen receptor inhibitor apalutamide, now branded as Erleada, has received approval from the …

Astellas scoops up Universal Cells for $102.5m

February 15, 2018
Sales and Marketing Astellas, Universal Cells, biotech, drugs, pharma, pharmaceutical

Astellas Pharma had only signed an exclusive licensing deal with Universal Cells back in October for the co-development of a …

kardia_mobile_give_credit_to_alivecor

Smartphone ECG device KardiaMobile rolled out to NHS to combat atrial fibrillation

February 14, 2018
Research and Development KardiaMobile, NHS, atrial fibrillation, pharma

AliveCor has announced that it has begun the rollout of its KardiaMobile technology to the NHS via the UK’s Academic …

New biotech facility to bring 350 jobs to Dublin

February 14, 2018
Manufacturing and Production, Research and Development Dublin, Ireland, MSD, pharma

MSD has announced plans to invest in a new biotechnology facility in Dublin which it claims will create 350 jobs …

Lilly posts promising P3 Taltz data

February 14, 2018
Research and Development Cosentyx, Eli Lilly, IL-17, Novartis, Taltz, biotech, drugs, pharma, pharmaceutical

The IL-17 market is a crowded space, and one dominated by Novartis’ Cosentyx. Eli Lilly is attempting to challenge that, …

merckincweb

MSD shuts down Phase 3 trial in prodromal Alzheimer’s

February 14, 2018
Research and Development Alzheimer's, MSD, pharma, verubecestat

Another blow has been dealt to the field of Alzheimer’s research as MSD announces yet another trial failure of a …

finland_flag

Pfizer taps real world evidence for CVD in new partnership

February 14, 2018
Research and Development BC Platforms, Pfizer, biotech, cardiovascular disease, drugs, pharma, pharmaceutical

BC Platforms, a company that focuses on genomic data managements and analysis, has announced that it has partnered with Pfizer …

Bill & Melinda Gates Foundation shows faith in CureVac

February 14, 2018
Research and Development, Sales and Marketing Bill & Melinda Gates foundation, biotech, drugs, influenza, pharma, pharmaceutical

The Bill & Melina Gates Foundation had already invested $52 million in CureVac, back in 2015, and has now doubled …

shutterstock_273326141

Roivant signs $600m licensing deal with Poxel

February 13, 2018
Manufacturing and Production, Sales and Marketing Poxel, Roivant, diabetes, imeglimin, pharma

Roivant Sciences has announced that it has entered into a licensing partnership with Poxel to develop and commercialise the latter’s …

cell-3089947_960_720

Vertex gets approval for combo-therapy in cystic fibrosis

February 13, 2018
Manufacturing and Production, Sales and Marketing Vertex, biotech, cystic fibrosis, drugs, pharma, pharmaceutical

All eyes are on Vertex’s two Phase 3 trials into a triple therapy for cystic fibrosis (CF), in the meantime, …

jason_drees_arizona_state_university

Cancer-targeting nanorobots successfully starve and shrink tumours, study shows

February 13, 2018
Manufacturing and Production, Research and Development Arizona State university, Cancer, Chinese Academy of Sciences, National Center for Nanoscience and Technology, nanorobots, pharma

A team of researchers from Arizona State University (ASU), in partnership with the Chinese Academy of Sciences’ National Center for …

pills-384846_960_720

Purdue pulls plug on opioid marketing

February 13, 2018
Manufacturing and Production, Sales and Marketing Purdue Pharma, biotech, drugs, opioid, opioid epidemic, pharma, pharmaceutical

Purdue Pharma was fined $643.5 million in 2007 for its part in creating the opioid epidemic that has plagued the …

flu

New flu med can destroy influenza virus in one day

February 13, 2018
Manufacturing and Production, Research and Development Roche, Shionongi, Tamiflu, biotech, drugs, flu, influenza, pharma, pharmaceutical

Researchers in Japan have achieved a notable success in a Phase 3 clinical trial to determine whether a new vaccine …

The Gateway to Local Adoption Series

Latest content